XERIS PHARMACEUTICALS INC

CUSIP: 98422LAA5 Class: Bond 30/360P2 U

LAZARD ASSET MANAGEMENT LLC's Holding History (CIK: 0001207017)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 11,500,000 Value ($000) $21 Avg Close — Range —
Q4 2024
Shares 11,500,000 Value ($000) $14 Avg Close — Range —
Q3 2024
Shares 11,500,000 Value ($000) $13 Avg Close — Range —
Q2 2024
Shares 11,500,000 Value ($000) $12 Avg Close — Range —
Q1 2024
Shares 11,500,000 Value ($000) $12 Avg Close — Range —
Q4 2023
Shares 11,500,000 Value ($000) $13 Avg Close — Range —
Q3 2023
Shares 11,500,000 Value ($000) $11 Avg Close — Range —
Q2 2023
Shares 11,500,000 Value ($000) $13 Avg Close — Range —
Q1 2023
Shares 10,500,000 Value ($000) $9 Avg Close — Range —
Q4 2022
Shares 10,500,000 Value ($000) $9 Avg Close — Range —
Q3 2022
Shares 10,500,000 Value ($000) $9,802 Avg Close — Range —
Q2 2022
Shares 10,500,000 Value ($000) $9,526 Avg Close — Range —
Q1 2022
Shares 10,500,000 Value ($000) $12,123 Avg Close — Range —
Q4 2021
Shares 10,500,000 Value ($000) $13,013 Avg Close — Range —
Q3 2021
Shares 10,500,000 Value ($000) $12,446 Avg Close — Range —
Q2 2021
Shares 10,000,000 Value ($000) $15,687 Avg Close — Range —
Q1 2021
Shares 10,625,000 Value ($000) $18,010 Avg Close — Range —
Q4 2020
Shares 7,875,000 Value ($000) $13,836 Avg Close — Range —
Q3 2020
Shares 4,000,000 Value ($000) $7,763 Avg Close — Range —
Q2 2020
Shares 3,500,000 Value ($000) $3,466 Avg Close — Range —